Prion Progress
ثبت نشده
چکیده
Although disease-causing prions are an extreme pathogenic aberration in protein behavior, emerging evidence places them at the end of a broad spectrum of ordered protein aggregates with diverse biological roles. This Select highlights recent findings on prions, including mutations that push proteins with prion-like domains over the threshold to pathogenicity in degenerative disorders, a vertebrate model of prion disease with the fastest known incubation time, and a system to examine howcytoplasmic prions are transmitted between cells. A unique therapeutic perspective is also offered by a recent study that suggests potential beneficial effects of prion-like amyloid fibrils in neuroinflammatory diseases, such as multiple sclerosis.
منابع مشابه
[Treatment for prion disease: recent progress].
Treatment for prion disease: recent progress
متن کاملFamilial Prion Disease Cases Without Mutation in PRNPGene
Phosphorus (P), in the form of phosphate ion (Pi), is a vital element contributing in biomolecule structures, metabolic reactions, signaling pathways and energy transfer within the living cells. The objective of the present study was to assess the influence of fungal infection on Pi metabolism in compare to the effects of phosphate stress in Arabidopsis. Quantification of total P contents showe...
متن کاملProgress and problems in the biology, diagnostics, and therapeutics of prion diseases.
The term "prion" was introduced by Stanley Prusiner in 1982 to describe the atypical infectious agent that causes transmissible spongiform encephalopathies, a group of infectious neurodegenerative diseases that include scrapie in sheep, Creutzfeldt-Jakob disease in humans, chronic wasting disease in cervids, and bovine spongiform encephalopathy in cattle. Over the past twenty years, the word "p...
متن کاملDeveloping Therapeutics for PrP Prion Diseases.
The prototypical PrP prion diseases are invariably fatal, and the search for agents to treat them spans more than 30 years, with limited success. However, in the last few years, the application of high-throughput screening, medicinal chemistry, and pharmacokinetic optimization has led to important advances. The PrP prion inoculation paradigm provides a robust assay for testing therapeutic effic...
متن کاملControlling the prion propensity of glutamine/asparagine-rich proteins
The yeast Saccharomyces cerevisiae can harbor a number of distinct prions. Most of the yeast prion proteins contain a glutamine/asparagine (Q/N) rich region that drives prion formation. Prion-like domains, defined as regions with high compositional similarity to yeast prion domains, are common in eukaryotic proteomes, and mutations in various human proteins containing prion-like domains have be...
متن کاملComputational simulations of the early steps of protein aggregation.
There is strong evidence that the oligomers of key proteins, formed during the early steps of aggregation, could be the primary toxic species associated with human neuro-degenerative diseases, such as Alzheimer's and prion diseases. Here, we review recent progress in the development of computational approaches in order to understand the structures, dynamics and free energy surfaces of oligomers...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cell
دوره 153 شماره
صفحات -
تاریخ انتشار 2013